5620 Inorg. Chem. 2009, 48, 5620–5622
DOI: 10.1021/ic9009042
Versatile Methodology Toward NiN2S2 Complexes as Nickel Superoxide Dismutase
Models: Structure and Proton Affinity
Eric M. Gale, Ashis K. Patra, and Todd C. Harrop*
Department of Chemistry, University of Georgia, 1001 Cedar St, Athens, Georgia 30602
Received May 10, 2009
Structural features of the reduced form of the nickel superoxide
dismutase (Ni-SOD) active site have been modeled with asym-
metric NiN2S2 complexes (Et4N)[Ni(nmp)(SR)] (R = C6H4-p-Cl (2)
and (StBu) (3)) obtained via S,S-bridge splitting of the dimeric
metallosynthon, [Ni2(nmp)2] (1). Complexes 2 and 3 are irreversibly
oxidized at potentials within the window needed for SOD activity,
236 and 75 mV versus Ag/AgCl, respectively. The exogenous
thiolato-S in 2 and 3 serves as a proton acceptor, suggesting
potential involvement of Cys6 in Ni-SOD for H+ storage between
SOD half reactions.
of this SOD.7,8 The overall protein fold, spectroscopy,
ligands, and coordination geometry in Ni-SOD are quite
distinct from those of other SODs. For example, Ni-SOD in
its reduced NiII form (Ni-SODred) is ligated in an N2S2
square-planar geometry arising from the primary amine-N
of His1, carboxamido-N from Cys2, and two thiolato-S
donors from Cys2 and Cys6 (Chart 1). The presence of
carboxamido-N and primary amine-N provides an unusual
set of donors and raises questions with regard to the proper-
ties they impart on the Ni center, with few examples known in
biology.9,10 Another striking feature of Ni-SOD is the pre-
sence of two coordinated cysteine thiolates, which are them-
selves subject to oxidation in the presence of ROS.11
Although the highly covalent nature of thiolate ligation is
believed to aid in modulating the NiII/NiIII redox couple to a
value suitable for physiological function,12 the interactions
directing metal-based redox are not yet fully understood.13,14
Additional questions arise as to how superoxide coordinates,
the source of protons in the oxidative half-reaction, and how
these tie into the overall Ni-SOD catalytic mechanism.
The report of Ni-SOD has inspired us and others15 to
answer these questions through small molecule analogues in
The reactive oxygen species (ROS) superoxide (O2•-) is an
inevitable cytotoxic byproduct of aerobic metabolism, which
if not eliminated can lead to a variety of health disorders.1 To
combat this ROS, all aerobic organisms possess metallo-
enzymes known as superoxide dismutases (SODs) that cata-
•-
lyze the disproportionation of O2 into hydrogen peroxide
(H2O2) and O2 through alternate oxidation and reduction of
their catalytic metal centers.2 These SODs have been exten-
sively characterized and employ metal cofactors such as Fe,3,4
Mn,5 or Cu/Zn6 to catalyze the disproportionation reaction.
Recently, a new class of SODs containing Ni (Ni-SOD) has been
characterized; however, less is known regarding the mechanism
Chart 1. Active Site of Ni-SODred and the Model Complexes, [Ni(nmp)
(SR)]-, Used in This Study (R = C6H4-p-Cl (2) or tBu (3))
*To whom correspondence should be adressed. E-mail: tharrop@chem.
uga.edu.
(1) (a) Beyer, W.; Imlay, J.; Fridovich, I. Prog. Nucleic Acid Res. Mol.
Biol. 1991, 40, 221. (b) Maritim, A. C.; Sanders, R. A.; Watkins, J. B.III.
J. Biochem. Mol. Toxicol. 2003, 17, 24. (c) Valentine, J. S.; Wertz, D. L.;
Lyons, T. J.; Liou, L.-L.; Goto, J. J.; Gralla, E. B. Curr. Opin. Chem. Biol.
1998, 2, 253.
(2) (a) Riley, D. P. Chem. Rev. 1999, 99, 2573. (b) Miller, A.-F. Curr. Opin.
Chem. Biol. 2004, 8, 162.
(3) Miller, A.-F. Acc. Chem. Res. 2008, 41, 501.
(4) Tierney, D. L.; Fee, J. A.; Ludwig, M. L.; Penner-Hahn, J. E.
Biochemistry 1995, 34, 1661.
(5) Borgstahl, G. E. O.; Parge, H. E.; Hickey, M. J.; Beyer, W. F. Jr.;
Hallewell, R. A.; Tainer, J. A. Cell 1992, 71, 107.
(6) Tainer, J. A.; Getzoff, E. D.; Richardson, J. S.; Richardson, D. C.
(9) Harrop, T. C.; Mascharak, P. K. Coord. Chem. Rev. 2005, 249, 3007.
(10) Lanzilotta, W. N.; Schuller, D. J.; Thorsteinsson, M. V.; Kerby,
R. L.; Roberts, G. P.; Poulos, T. L. Nat. Struct. Biol. 2000, 7, 876.
(11) Grapperhaus, C. A.; Darensbourg, M. Y. Acc. Chem. Res. 1998, 31,
451.
(12) Fiedler, A. T.; Bryngelson, P. A.; Maroney, M. J.; Brunold, T. C.
J. Am. Chem. Soc. 2005, 127, 5449.
Nature 1983, 306, 284.
(7) (a) Youn, H.-D.; Kim, E.-J.; Roe, J.-H.; Hah, Y. C.; Kang, S.-O.
Biochem. J. 1996, 318, 889. (b) Youn, H.-D.; Youn, H.; Lee, J.-W.; Yim,
Y.-I.Lee, J. K.; Hah, Y. C.; Kang, S.-O. Arch. Biochem. Biophys. 1996,
334, 341.
(8) (a) Barondeau, D. P.; Kassmann, C. J.; Bruns, C. K.; Tainer, J. A.;
Getzoff, E. D. Biochemistry 2004, 43, 8038. (b) Wuerges, J.; Lee, J.-W.; Yim,
Y.-I.; Yim, H.-S.; Kang, S.-O.; Carugo, K. D. Proc. Natl. Acad. Sci. U.S.A.
2004, 101, 8569.
(13) Mullins, C. S.; Grapperhaus, C. A.; Kozlowski, P. M. J. Biol. Inorg.
Chem. 2006, 11, 617.
(14) (a) Shearer, J.; Dehestani, A.; Abanda, F. Inorg. Chem. 2008, 47,
2649. (b) Neupane, K. P.; Shearer, J. Inorg. Chem. 2006, 45, 10552.
r
2009 American Chemical Society
pubs.acs.org/IC
Published on Web 06/05/2009